Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ahmadi, Majid  [Clear All Filters]
2021
Budi HSetia, Izadi S, Timoshin A, Asl SHeydarzade, Beyzai B, Ghaderpour A, Alian F, Eshaghi FSadat, Mousavi SMahboubeh, Rafiee B, et al. Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine. 2021:102373.
Shabgah AGowhari, Al-Qaim ZHaleem, Markov A, Yumashev AValerievic, Ezzatifar F, Ahmadi M, Gheibihayat SMohammad, Navashenaq JGholizadeh. Chemokine CXCL14; a double-edged sword in cancer development. Int Immunopharmacol. 2021;97:107681.
Shabgah AGowhari, Abdelbasset WKamal, Rahman HSulaiman, Bokov DO, Suksatan W, Thangavelu L, Ahmadi M, Malekahmadi M, Gheibihayat SMohammad, Navashenaq JGholizadeh. A comprehensive review of IL-26 to pave a new way for a profound understanding of the pathobiology of cancer, inflammatory diseases, and infections. Immunology. 2021.
Dauletova M, Hafsan H, Mahhengam N, Zekiy AOlegovna, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol. 2021:108712.
Tahmasebi S, Saeed BQubais, Temirgalieva E, Yumashev AValerievic, El-Esawi MA, Navashenaq JGholizadeh, Valizadeh H, Sadeghi A, Aslani S, Yousefi M, et al. Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sci. 2021:119437.
Aravindhan S, Younus LA, Lafta MHadi, Alexander M, Enina YIvanovna, Yushchenkо NA, Thangavelu L, Mostafavi SMojtaba, Pokrovskii MV, Ahmadi M. P53-long noncoding RNA regulatory network in cancer development. Cell Biol Int. 2021.
Kiani FKaroon, Izadi S, Dezfouli EAnsari, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MMortazavi, Esfahani MNasr, Karpisheh V, Khesht AMahmoud Sa, et al. Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sci. 2021:120166.
Vakili-Samiani S, Jalil ATurki, Abdelbasset WKamal, Yumashev AValerievic, Karpisheh V, Jalali P, Adibfar S, Ahmadi M, Feizi AAli Hossei, Jadidi-Niaragh F. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. DNA Repair (Amst). 2021;107:103203.
2018
Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, et al. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease. J Cell Physiol. 2018.
Eghbal-Fard S, Yousefi M, Heydarlou H, Ahmadi M, Taghavi S, Movasaghpour A, Jadidi-Niaragh F, Yousefi B, Dolati S, Hojjat-Farsangi M, et al. The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia. J Cell Physiol. 2018.
Jafarzadeh S, Ahmadi M, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Kamrani A, Behrad B, Roshangar L, Jadidi-Niaragh F, Yousefi B, et al. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function. J Cell Biochem. 2018.
Ahmadi M, Ghaebi M, Abdolmohammadi-Vahid S, Abbaspour-Aghdam S, Hamdi K, Abdollahi-Fard S, Danaii S, Mosapour P, Koushaeian L, Dolati S, et al. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss. J Cell Physiol. 2018.
Ghaebi M, Abdolmohammadi-Vahid S, Ahmadi M, Eghbal-Fard S, Dolati S, Nouri M, Talebi M, Hamdi K, Marofi F, Aghebati-Maleki L, et al. T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. J Reprod Immunol. 2018;131:21-29.